Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-α production

Biochemical and Biophysical Research Communications

Volumn 224, Issue 2, 1996, Pages 426-430

  Miyachi, Hiroyuki ^a   Azuma, Akihiko ^a   Hioki, Erika ^a   Iwasaki, Shigeo ^a   Kobayashi, Yoshiro ^b   Hashimoto, Yuichi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ISOINDOLE DERIVATIVE; OKADAIC ACID; PHENYL GROUP; PHORBOL 13 ACETATE 12 MYRISTATE; THALIDOMIDE; THALIDOMIDE DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; STRUCTURE ACTIVITY RELATION;

EID: 0030590082     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1996.1043     Document Type: Article

References (21)

1. 1. Makonkawkeyoon, S., Limson-Pombre, R. N. R., Moreira, A. L., Schauf, V., and Kaplan, G. (1993) Proc. Natl. Acad. Sci. USA 90, 5974-5978.
2. 2. Parker, P. M., Chao, N., Nademanee, A., O'Donnell, M., Schmidt, G. M., Snyder, D. S., Stein, A. S., Smith, E. P., Molina, A., Stepan, D. E., Kashyap, A., Planas, I., Spielberger, R., Somlo, G., Margolin, K., Zwingenberger, K., Wilsman, K., Negrin, R. S., Long, G., Niland, J. C., Blume, K. G., and Forman, S. J. (1995) Blood 86, 3604-3609.
3. 3. Atra, E., and Sato, E. I. (1993) Clin. Exp. Rheumatol. 11, 487-493.
4. 4. Ochonisky, S., and Revuz, J. (1994) Eur. J. Dermatol. 4, 9-15.
5. 5. Kelsey, F. O. (1988) Teratology 38, 221-226.
6. 6. Sampio, E. P., Sarno, E. N., Galilly, R., Cohn, Z. A., and Kaplan, G. (1991) J. Exp. Med. 173, 699-703.
7. 7. Siadak, K., and Sullivan, K. M. (1994) Blood Rev. 8, 154-160.
8. 8. Shibata, Y., Sasaki, K., Nishimura, K., Hashimoto, Y., and Iwasaki, S. (1994) Biochem. Biophys. Res. Comm. 205, 1992-1997.
9. 9. Shibata, Y., Sasaki, K., Nishimura, K., Hashimoto, Y., and Iwasaki, S. (1996) Chem. Pharm. Bull. 44, 156-162.
10. 10. Shibata, Y., Sasaki, K., Nishimura, K., Hashimoto, Y., and Iwasaki, S. (1995) Biol. Pharm. Bull. 18, 1228-1233.
11. 11. Shibata, Y., Sasaki, K., Nishimura, K., Hashimoto, Y., and Iwasaki, S. (1994) Biol. Pharm. Bull. 17, 1532-1534.
12. 12. Tranontana, J. M., Utaipat, U., Molloy, A., Akarasewi, P., Burroughs, M., Makonkawkeyoon, S., Johnson, B., Klausner, J. D., Rom, W., and Kaplan, G. (1995) Mol. Med. 1, 384-397.
13. 13. Fujiki, H., and Suganuma, M. (1989) J. Environ. Sci. Health, Part C, Environ. Carcino. Rev. C7(1), 1-51.
14. 14. Komori, A., Yatsunami, J., Suganuma, M., Okabe, M., Abe, A., Sakai, A., Sasaki, K., and Fujiki, H. (1993) Cancer Res. 53, 1982-1985.
15. 15. Sung, S.-S., Walters, J. A., and Fu, S. M. (1992) J. Exp. Med. 176, 897-901.
16. 16. Hashimoto, Y., and Shudo, K. (1990) Biochem. Biophys. Res. Comm. 166, 1126-1132.
17. 17. Hashimoto, Y., and Shudo, K. (1991) Jpn. J. Cancer Res. 82, 665-675.
18. 18. Mizoguchi, H., Fukasawa, H., Steuernagel, A., Yano, K., and Yamasaki, M. (1994) Biol. Pharm. Bull. 17, 1114-1117.
19. 19. Fujiki, H., and Suganuma, M. (1993) Adv. Cancer Res. 61, 143-194.
20. 20. Mohri, M., Spriggs, D. R., and Kufe, D. (1990) J. Immunol. 144, 2678-2682.
21. 21. Komori, A., Suganuma, M., Okabe, S., Zou, X., Tius, M. A., and Fujiki, H. (1993) Cancer Res. 53, 3462-3464.